Clinical Trials Browser

Locally Advanced Cervical Cancer

Limited Stage Small Cell Lung Cancer

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

Leukemia, Myeloid, Acute

Papillomavirus Infections

Platinum Resistant Ovarian Cancer

Leukemia, Myeloid, Acute

COVID-19, Lymphopenia

Breast Neoplasms

Ototoxicity, Hearing Loss

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Breast Neoplasms

Breast Neoplasms

Cachexia, Fatigue, Lung Neoplasms

Solid Tumor Refractory to Standard Therapy

Neoplasms, Pancreatic Neoplasms

Neutropenia, Colorectal Neoplasms, Febrile Neutropenia

Digestive Tract

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Castrate-Resistant Prostate Cancer

Carcinoma, Non-Small-Cell Lung

Leukemia, Myeloid, Acute

Breast Neoplasms, Recurrence

Neoplasm Metastasis, Prostatic Neoplasms

Tissue Adhesions, Myoma

Melanoma, Skin Neoplasms

Clinical Trials

eVOLVECervical

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

MK 7339-013

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

V503-049

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

AML

ILIAD-7-US-O

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

PRESERVE 4

CATHY

Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

SHERBOC

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

PLIANT

Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract .

START2

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)

INSPIRE

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

STRIDE

A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer

BAP

AGENDA